AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05491616 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: In this SANO-3 study, patients will receive Nivolumab at 480mg Q4W starting 10-14 weeks after nCRT (i.e., when cCR has been established) until disease progression or unacceptable toxicity, for a maximum duration of 1 year.
Study NCT05048979 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Telehealth-facilitated supervised exercise program. Veterans with PAD will be enrolled in a 12-week, 3 day a week, aerobic training program in a self-selected location.
Study NCT04621981 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sodium Bicarbonate Ringer's Solution
Description: This group was treated with Sodium Bicarbonate Ringer's Solution.
Study NCT04621981 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Normal Saline
Description: This group was treated with normal saline.
Study NCT06333184 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Food
Description: Fruit ingested in whole form or as either commercially available, or home-made smoothies
Study NCT06333184 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Food
Description: Fruit ingested in whole form or as either commercially available, or home-made smoothies
Study NCT04648280 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fostemsavir
Description: fostemsavir in combination with optimized background therapy (OBT) in HIV-1 infected children and adolescents who are failing their current combination antiretroviral therapy (cART) and have dual- or triple-class ARV resistance
Study NCT04841122 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Camera observation
Description: Supplemental camera observation directly linked to the nurse's phone
Study NCT05366335 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Live Combined Bifidobacterium and Lactobacillus
Description: The invesitigators give patients Live Combined Bifidobacterium and Lactobacillus solution infusion during their colonoscopy examination for a single time in the Live Combined Bifidobacterium and Lactobacillus group.
Study NCT05366335 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal saline
Description: The invesitigators give patients normal saline as a placebo infusion during their colonoscopy examination for a single time in the control group.
Study NCT05366335 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Basic treatment
Description: The invesitigators give patients general treatment and drug treatment including oral Live Combined Bifidobacterium and Lactobacillus tablets as basic treatment.
Study NCT05366335 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Basic treatment
Description: The invesitigators give patients general treatment and drug treatment including oral Live Combined Bifidobacterium and Lactobacillus tablets as basic treatment.
Study NCT05951114 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Maximum inspiratory/Expiratory manoeuvre for patients can follow the order
Description: Bedside ultrasound will be performed for each patient at the time before, after surgery, before and after extubation, and at the time of ICU discharge, under the end-expiratory occlusion, maximum inspiratory, and/or expiratory manoeuvre
Study NCT05525897 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Psychoeducational
Description: The focus of the course is to teach students the fundamental theories, and practices of soft skills, as well as providing cases and material that give students the opportunity to learn from real life experiences.
Study NCT06070779 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: neuro linguistic programming
Description: neuro linguistic programming
Study NCT06052475 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Physiological Pacing Upgrade (Conduction System Pacing or Biventricular Pacing)
Description: The approach for physiological pacing upgrade will be either His bundle pacing or left bundle pacing at the operator's discretion. If both of these are not achieved biventricular pacing will be performed.
Study NCT06052475 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Continued RV Pacing (Right Ventricular Pacing)
Description: Right ventricular pacing (apical or septal lead locations as per the implanting physicians' normal practice).
Study NCT06605495 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral herbal medicine
Description: Patients were identified into the appropriate group according to the individual evidence profile, and the herbal formula under the corresponding evidence profile was taken orally as one dose of 150 ml of water twice a day for 6 weeks.
Study NCT06605495 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Modern Western Medicine
Description: Referring to the Chinese Expert Consensus on Dry Eye: Treatment (2020), this course of treatment totaled 6 weeks.
Study NCT06598605 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Parental Reflective Functioning Workshop
Description: Four online workshop sessions via Zoom will be based on psycho-educational knowledge concerning emotional regulation and specialized in autism. The group size will be up to 15 participants, with each session lasting an hour and a half, after which participants will be asked to complete a reflective journal.
Study NCT06610916 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Reinforced Communautary Support Program (PARC)
Description: Participants will complete the initial self-questionnaire collecting baseline socio-demographic, clinical characteristics, and all intermediate effectiveness outcome criteria \&amp;#34;before\&amp;#34;. Concurrently with their participation in the program, they will complete various intermediate effectiveness evaluation questionnaires (\&amp;#34;after\&amp;#34;) at 3 months (end of PARC) and 6 months (Post-PARC). Healthcare professionals running the PARC program will also complete questionnaires related to implementation indicators throughout the patients\&amp;#39; course (Adoption, Implementation, Maintenance).~Qualitative interviews will be conducted with patients and relevant healthcare professionals to explore barriers and drivers to the optimal deployment of the PARC program and to examine each of the Reach, Adoption, Implementation, Maintenance indicators through an organizational approach
Study NCT06609915 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: supraglottic superimposed high frequency jet ventilation ventilation using the Monsoon 4 (Thora Tech GmbH, Giessen, Germany)
Description: supraglottic superimposed high frequency jet ventilation ventilation using the Monsoon 4 (Thora Tech GmbH, Giessen, Germany). Initially FiO2 at 1.0, reduced to 0.3 during laser interventions. Frequency and pressure set according to the local standards
Study NCT06609915 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: High-flow nasal supplemental oxygen via nasal cannula with the Optiflow (Fisher & Paykel, Auckland, New Zealand)
Description: up to 70 L/min FiO2 1.0 high flow oxygen via nasal cannula with the Optiflow (Fisher \& Paykel, Auckland, New Zealand) initially. Reduced FiO2 to 0.3 during laser intervention.
Study NCT04758572 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Manual Therapy
Description: Mobilization, massage and stretching
Study NCT04758572 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Massage muscle chain
Description: Massage very soft following the directions of the muscle chains, massage and stretching
Study NCT05344950 — intervention group
Intervention type: BEHAVIORAL
Intervention: Audio + Radio (AURA)
Description: Participants will receive personalized self-care information based on their symptoms and signs of complications (e.g., fatigue) from interacting with our voice assistant device, connected to a system that integrating the patient-reported outcome and objective data from passive RF sensing to provide continuous monitoring of patients' symptoms and complications after they are discharged home.
Study NCT04875325 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standardized surveillance
Description: Standardized 3-monthly surveillance with routine imaging and serum tumor marker testing.
Study NCT05973942 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Wingman-Connect
Description: Training occurs in three 2-hr blocks over several days. Targeted Skills focus on protective factors (Four Cores) supportive of mental health, theoretically linked to reduced suicide risk, and essential to an Airmen's job success: (1) Healthy relationships and accountability spanning USAF and family/intimate relationships (Kinship); (2) Meaning and value in work and life (Purpose), (3) Informal and formal help-seeking (Guidance); and (4) Activities that give strength and balance emotions (Balance). Activities progress from individual to group skill-building activities. Kinship modules at operational base (FTAC) expand focus on growing and sustaining relationships with intimate partners, friends, and family; and Guidance more on senior mentors at work.
Study NCT06018350 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Clinician-led adherence intervention
Description: The clinician will review real time pharmacy refill data during clinic and use effective communication techniques to discuss adherence with the patient
Study NCT05757843 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Signatera ctDNA test
Description: The first mandatory ctDNA test will be done at screening for the bespoke ctDNA profiling. The next mandatory ctDNA test will be completed prior to the 5th cycle of consolidation Durvalumab. ctDNA testing will be repeated approximately every 4 weeks until two consecutive negative analyses occur. ctDNA testing will be otherwise discontinued after progressive disease or after up to 1 year of consolidation treatment per standard medical practice is considered complete, whichever occurs first.
Study NCT05757843 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Durvalumab
Description: All subjects will receive consolidation Durvalumab approximately every 4 weeks. Durvalumab will be stopped after two consecutive negative ctDNA analyses occur.
Study NCT05719311 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: adrulipase
Description: Enteric microgranule formulation of adrulipase.
Study NCT06258369 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Patients with primary coxarthrosis (any stage).
Description: Patients who do not undergo surgery will be called specifically for the study to attend a consultation dedicated to gait assessment.
Study NCT06258369 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Patients with primary coxarthrosis (any stage) and operated with Total Hip Prosthesis (THP).
Description: Patients scheduled for THP (Total Hip Prosthesis) will be seen at the consultation the day before surgery, in the same hospital as the THP, or at an existing dedicated consultation scheduled for all THP patients. During these scheduled visits, they will be received in the gait analysis laboratory for a gait assessment (V1). Patients will be seen again at 6 months post-operatively for a second gait assessment (V2).
Study NCT06258369 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Patients with primary coxarthrosis (any stage) and operated with RTH (Hip resurfacing).
Description: Patients scheduled for RTH (Hip Resurfacing) will be seen at the consultation the day before surgery, in the same hospital as the RTH, or at an existing dedicated consultation scheduled for all RTH patients. During these scheduled visits, they will be received in the gait analysis laboratory for a gait assessment (V1). Patients will be seen again at 6 months post-operatively for a second gait assessment (V2).
Study NCT05021354 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Dry needling
Description: dry needling, stretching and eccentric exercise
Study NCT05021354 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Topical gel
Description: aplication of topical gel to the epicondyle
Study NCT05021354 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: NSAIDs
Description: oral intake of NSAIDs
Study NCT05380973 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Short fiber resin composite
Description: resin composite reinforced with short glass fibers
Study NCT05380973 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Short fiber resin composite
Description: resin composite reinforced with short glass fibers
Study NCT05380973 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Polyethylene ribbon fiber
Description: resin composite reinforced with polyethylene ribbon fiber
Study NCT05380973 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Polyethylene ribbon fiber
Description: resin composite reinforced with polyethylene ribbon fiber
Study NCT05136976 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rituximab infusion
Description: 2 infusions of 1 gram of rituximab at a 2 week interval (day 1 followed by day 15).
Study NCT05136976 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo infusion
Description: 2 infusions of placebo at a 2 week interval.
Study NCT05136976 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Premedications
Description: Premedications prior to rituximab or placebo infusions:~* IV Dexchlorpheniramine Maleate IV: 10 mg~* IV Methylprednisolone: 40 mg~* PO Paracetamol : 1 gram
Study NCT05136976 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Premedications
Description: Premedications prior to rituximab or placebo infusions:~* IV Dexchlorpheniramine Maleate IV: 10 mg~* IV Methylprednisolone: 40 mg~* PO Paracetamol : 1 gram
Study NCT04921670 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Infliximab Assay
Description: Participants will be assigned to standard of care or proactive drug monitoring, which is measuring infliximab levels/antibodies before every infusion
Study NCT05282095 — intervention group
Intervention type: OTHER
Intervention: Follow up
Description: Participants will be followed up at baseline, 3th, 6th, 9th and 12th months with HPV viral integration tests, HPV genotyping tests, thinprep cytologic tests (TCT) for cervix and vaginal secretion tests. Colposcopies and biopsies will be performed on the participants at 6 - and 12-month follow-up.
Study NCT06311838 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing/Community Reinforcement Approach (MI/CRA)
Description: MI/CRA includes two Motivational Interviewing sessions and twelve 1-hour Community Reinforcement Approach sessions.
Study NCT06311838 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Strengths-Based Outreach and Advocacy (SBOA )
Description: The number of Strengths-Based Outreach and Advocacy sessions participants will receive are flexibly determined based upon youth needs.
Study NCT06311838 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Services as Usual (SAU)
Description: Participants assigned to this group will receive the standard services provided to all youth involved with the drop-in center.
Study NCT06311838 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Services as Usual (SAU)
Description: Participants assigned to this group will receive the standard services provided to all youth involved with the drop-in center.
Study NCT05146388 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EHR-Based Approach
Description: The intervention will be built directly into the EHR. E-prescriptions will be generated with pharmacy instructions for all prescription medications. The intervention will impart: 1) inclusion with e-Rx request for pharmacy to keep metric-only (mL-only) dosing on Rx label and 2) inclusion of guidance on the e-Rx requesting that the pharmacy give an optimal tool based on an algorithm. Algorithm for dosing tool recommendation: 1) for a prescribed dose of \<= 1mL, optimal tool is 1 mL syringe, 2) for >1 mL to 5 mL, use a 5 mL syringe, 3) for >5mL to 10mL, use 10 mL syringe.
Study NCT06548776 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Spectroscopy (MRS) Scan
Description: Participants will receive MRS Scan
Study NCT06571253 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Digital Exercise Intervention
Description: Participants in this intervention arm used the Fiziu Digital Physiotherapy Platform. This digital platform provided a structured 6-week corrective exercise program through visual and auditory-guided videos. The intervention included interactive features such as reminders and progress tracking to enhance adherence and engagement.
Study NCT06571253 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Paper-Based Exercise Intervention
Description: Participants in this intervention arm followed a traditional paper-based exercise program. This included printed exercise instructions and illustrations for a 6-week period. The program was designed to mimic standard physical therapy exercises without digital support.
Study NCT06222866 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Anticoagulation monitoring
Description: Evaluation of different monitoring modalities to find the most appropriate anticoagulation monitoring tool for UFH therapy
Study NCT05703945 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Progressive training program
Description: The intervention consists of progressive training program : toe plantar flexion isometric at 30° of dorsal flexion of the metatarsophalangeal joint (0° is considered the anatomical position). The training will be performed in the same customized device used for the measurement. Each session consists of four sets at 80% of the maximal voluntary contraction performed until task failure. Between the sets, 2 minutes of rest will be allowed. Maximal voluntary contraction estimate will be updated every session of training, testing it before the start. The test is considered part of the training intervention. The total impulse performed during the single session will be recorded. Participants will train twice a week for 8 weeks. Training will be performed with both the feet.
Study NCT05703945 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Control group
Description: The control group will not perform the progressive training program after visit 2 and will continue all of their daily activities during the 8-week intervention period.
Study NCT04101955 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Incisionless Threaded Carpal Tunnel
Description: ultra-minimally invasive thread carpal tunnel release
Study NCT04101955 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Standard Mini-Open Carpal Tunnel
Description: open surgical carpal tunnel release
Study NCT05985161 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Selinexor
Description: This phase II study will initially treat all patients, including adult patients, at the pediatric Selinexor RP2D of 35 mg/m2 (no maximum dose) once weekly using a liquid suspension .
Study NCT06581016 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ambu aScope Gastro
Description: CE-marked single-use gastroscopes from Ambu are used in the single-use group.
Study NCT06581016 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ambu aScope Gastro Large
Description: CE-marked single-use gastroscopes from Ambu are used in the single-use group.
Study NCT06581016 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Diagnostic gastroscopes, Olympus
Description: Reusable gastroscopes from Olympus are used in the reusable group.
Study NCT06581016 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Therapeutic gastroscopes, Olympus
Description: Reusable gastroscopes from Olympus are used in the reusable group.
Study NCT04534244 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: VBox Hybrid
Description: Medical device intended to treat permanent venous insufficiency of saphenous veins and tributary veins in patients with superficial venous reflux
Study NCT05975671 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Multifaceted de-implementation strategy to reduce vancomycin overuse
Description: * Clinical guidelines and group-level feedback on vancomycin use will be provided to clinicians/sepsis stakeholders at each site.~* The semi-structured interviews will be performed by a trained member of the research team, under the supervision of a medical sociologist who is one of the co-investigators. A semi-structured interview guide will be used during the interviews. Interviews will be recorded and transcribed, then uploaded to a qualitative analysis software for management and coding. Names will not be recorded, and pseudonyms will be used in notes, communications about the study, and any presentations. Verbal consent will be obtained before conducting and recording the interviews.~* The surveys will be performed using REDCap survey software, and participation will be voluntary. No identifiers will be collected.
Study NCT05899634 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Defaults
Description: Participants will receive healthy recipes (3 main meal + 1 snack/breakfast/lunch recipe per week of the two-week intervention). In addition, in this group, participants' online grocery shopping carts will be pre-filled with ingredients corresponding to the provided recipes. They will be told that their cart has been filled with items that can be used to make recipes from the provided recipe cards, and that they can modify it as they like.
Study NCT05641545 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: IVAC
Description: IVAC is a personalized peptide vaccine
Study NCT05757505 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intracranial Stent (Tonbridge)
Description: Endovascular treatment with Intracranial Stent (Tonbridge).
Study NCT05757505 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Wingspan Stent System (Stryker Neurovascular)
Description: Endovascular treatment with Wingspan Stent System (Stryker Neurovascular).